x |
Quarterly
report under Section 13 or 15(d) of the Securities Exchange Act of
1934
for the quarterly period ended September 30,
2008.
|
o |
Transition
report under Section 13 or 15(d) of the Securities Exchange Act of
1934
|
Nevada
|
91-2048978
|
(State
of Incorporation)
|
(IRS
Employer Identification No.)
|
PART
I. FINANCIAL INFORMATION
|
||||
Item
1.
|
Financial
Statements
|
|||
Condensed
Consolidated Balance Sheets:
|
||||
September
30, 2008 (Unaudited) and December 31, 2007 (Audited)
|
3
|
|||
Condensed
Consolidated Statements of Losses:
|
||||
Three
and Nine months Ended September 30, 2008 and 2007
(Unaudited)
|
4
|
|||
Condensed
Consolidated Statements of Cash Flows:
|
|
|||
Nine
months Ended September 30, 2008 and 2007 (Unaudited)
|
5
|
|||
|
||||
Notes
to Unaudited Condensed Consolidated Financial Information:
|
||||
September
30, 2008
|
6-36
|
|||
Item
2.
|
Management
Discussion and Analysis
|
37
|
||
|
|
|||
Item
3.
|
Controls
and Procedures
|
43
|
||
PART
II. OTHER INFORMATION
|
||||
Item
1.
|
Legal
Proceedings
|
44
|
||
Item
2.
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
44
|
||
Item
3.
|
Defaults
Upon Senior Securities
|
45
|
||
Item
4.
|
Submission
of Matters to a Vote of Security Holders
|
45
|
||
Item
5.
|
Other
Information
|
45
|
||
Item
6.
|
Exhibits
|
45
|
||
Signatures
|
46
|
CYBERLUX
CORPORATION
|
|||||||
CONDENSED
CONSOLIDATED BALANCE SHEETS
|
|||||||
(unaudited)
|
|||||||
September
30,
|
December
31,
|
||||||
2008
|
2007
|
||||||
ASSETS
|
|||||||
Current
assets:
|
|||||||
Cash
& cash equivalents
|
$
|
290
|
$
|
626
|
|||
Accounts
receivable, net of allowance for doubtful accounts of
$1,803
|
53,927
|
77,815
|
|||||
Inventories,
net of allowance of $43,333
|
54,251
|
157,379
|
|||||
Other
current assets
|
17,500
|
10,000
|
|||||
Total
current assets
|
125,968
|
245,820
|
|||||
Property,
plant and equipment, net of accumulated depreciation of $189,338
and
$169,171, respectively
|
54,440
|
74,607
|
|||||
Other
assets
|
|||||||
Deposits
|
24,400
|
24,400
|
|||||
Patents
and development costs, net of accumulated amortization of $1,214,056
and
$819,639, respectively
|
2,760,918
|
3,155,335
|
|||||
Total
other assets
|
2,785,318
|
3,179,735
|
|||||
Total
Assets
|
$
|
2,965,726
|
$
|
3,500,162
|
|||
LIABILITIES
AND DEFICIENCY IN STOCKHOLDERS' EQUITY
|
|||||||
Current
liabilities:
|
|||||||
Cash
overdraft
|
$
|
7,137
|
$
|
33,178
|
|||
Accounts
payable
|
1,050,295
|
733,538
|
|||||
Accrued
liabilities
|
2,978,209
|
2,345,133
|
|||||
Short-term
notes payable - related parties
|
418,823
|
397,064
|
|||||
Short-term
notes payable
|
39,804
|
196,067
|
|||||
Short-term
convertible notes payable
|
4,805,175
|
3,050,510
|
|||||
Total
current liabilities
|
9,299,443
|
6,755,490
|
|||||
Long-term
liabilities:
|
|||||||
Derivative
liability relating to convertible debentures
|
23,899,079
|
17,334,621
|
|||||
Warrant
liability relating to convertible debentures
|
977,938
|
4,509,538
|
|||||
Total
long-term liabilities
|
24,877,017
|
21,844,159
|
|||||
Total
liabilities
|
34,176,460
|
28,599,649
|
|||||
Commitments
and Contingencies
|
|||||||
Redeemable
Series A convertible preferred stock, $0.001 par value; 200 shares
designated, 26.9806 and 28.9806 issued and outstanding as of September
30,
2008 and December 31, 2007; liquidation preference of $219,892 and
$231,845 as of September 30, 2008 and December 31, 2007,
respectively
|
134,900
|
144,900
|
|||||
DEFICIENCY
IN STOCKHOLDERS' EQUITY
|
|||||||
Class
B convertible preferred stock, $0.001 par value, 3,650,000 shares
designated; 3,650,000 shares issued and outstanding for September
30, 2008
and December 31, 2007; liquidation preference of $3,650,000 as of
September 30, 2008 and December 31, 2007
|
3,650
|
3,650
|
|||||
Class
C convertible preferred stock, $0.001 par value, 700,000 shares
designated; 150,000 shares issued and outstanding for September 30,
2008
and December 31, 2007, liquidation preference of $3,910,490 and
$3,823,230, as of September 30, 2008 and December 31, 2007,
respectively
|
150
|
150
|
|||||
Common
stock, $0.001 par value, 900,000,000 shares authorized; 717,713,999and
552,342,881 shares issued and outstanding as of September 30, 2008
and
December 31, 2007
|
717,714
|
552,343
|
|||||
Additional
paid-in capital
|
17,162,032
|
15,286,709
|
|||||
Accumulated
deficit
|
(49,229,180
|
)
|
(41,087,239
|
)
|
|||
Deficiency
in stockholders' equity
|
(31,345,634
|
)
|
(25,244,387
|
)
|
|||
Total
liabilities and (deficiency) in stockholders' equity
|
$
|
2,965,726
|
$
|
3,500,162
|
|||
The
accompanying notes are an integral part of these condensed consolidated
financial statements
|
CYBERLUX
CORPORATION
|
|||||||||||||
CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS
|
|||||||||||||
(unaudited)
|
|||||||||||||
Three
months ended September 30,
|
Nine
months ended September 30,
|
||||||||||||
2008
|
2007
|
2008
|
2007
|
||||||||||
REVENUE:
|
$
|
69,256
|
$
|
298,459
|
$
|
401,162
|
$
|
521,814
|
|||||
Cost
of goods sold
|
(47,295
|
)
|
(227,932
|
)
|
(267,815
|
)
|
(402,608
|
)
|
|||||
Gross
margin (loss)
|
21,961
|
70,527
|
133,347
|
119,206
|
|||||||||
OPERATING
EXPENSES:
|
|||||||||||||
Depreciation
|
6,209
|
5,332
|
20,167
|
16,981
|
|||||||||
Research
and development
|
—
|
42,466
|
1,386
|
121,951
|
|||||||||
General
and administrative expenses
|
1,351,634
|
629,606
|
2,890,873
|
2,865,387
|
|||||||||
Total
operating expenses
|
1,357,843
|
677,404
|
2,912,426
|
3,004,319
|
|||||||||
NET
LOSS FROM OPERATIONS
|
(1,335,882
|
)
|
(606,877
|
)
|
(2,779,079
|
)
|
(2,885,113
|
)
|
|||||
Debt
forgiveness
|
—
|
—
|
—
|
381,652
|
|||||||||
Unrealized
gain (loss) relating to adjustment of derivative and warrant liability
to
fair value of underlying securities
|
2,754,714
|
(56,164,992
|
)
|
(3,032,859
|
)
|
(65,227,499
|
)
|
||||||
Interest
expense, net
|
(517,553
|
)
|
(631,731
|
)
|
(1,887,066
|
)
|
(1,829,729
|
)
|
|||||
Debt
acquisition costs
|
9,289
|
(34,381
|
)
|
(442,423
|
)
|
(77,751
|
)
|
||||||
Net
Income (loss) before provision for income taxes
|
910,568
|
(57,437,981
|
)
|
(8,141,427
|
)
|
(69,638,440
|
)
|
||||||
Income
taxes (benefit)
|
—
|
—
|
515
|
—
|
|||||||||
INCOME
(LOSS) AVAILABLE TO COMMON STOCKHOLDERS
|
$
|
910,568
|
$
|
(57,437,981
|
)
|
$
|
(8,141,942
|
)
|
$
|
(69,638,440
|
)
|
||
Weighted
average number of common shares outstanding-basic
|
667,942,486
|
494,297,678
|
602,506,202
|
327,087,037
|
|||||||||
Weighted
average number of common shares outstanding-fully diluted
|
Note
A
|
||||||||||||
Income
(loss) per share-basic
|
$
|
0.00
|
$
|
(0.12
|
)
|
$
|
(0.01
|
)
|
$
|
(0.21
|
)
|
||
Loss
per share-fully diluted
|
Note
A
|
||||||||||||
Preferred
dividend
|
$
|
24,000
|
$
|
24,000
|
$
|
72,000
|
$
|
72,000
|
|||||
The
accompanying notes are an integral part of these condensed consolidated
financial statements
|
CYBERLUX
CORPORATION
|
|||||||
CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOW
|
|||||||
(unaudited)
|
|||||||
Nine
months ended September 30,
|
|||||||
2008
|
2007
|
||||||
CASH
FLOWS FROM OPERATING ACTIVITIES:
|
|||||||
Net
income (loss) available to common stockholders
|
$
|
(8,141,942
|
)
|
$
|
(69,638,440
|
)
|
|
Adjustments
to reconcile net income (loss) to cash used in operating
activities
|
|||||||
Depreciation
|
20,167
|
16,981
|
|||||
Amortization
|
394,417
|
394,417
|
|||||
Common
stock issued in connection issuance of debt
|
385,108
|
—
|
|||||
Common
stock issued in connection with services rendered
|
878,800
|
118,110
|
|||||
Preferred
stock issued as compensation
|
—
|
370,500
|
|||||
Gain
on repurchase and cancellation of warrants
|
(381,652
|
)
|
|||||
Beneficial
conversion feature relating to convertible debenture
|
184,736
|
—
|
|||||
Accretion
of convertible notes payable
|
1,254,665
|
1,408,058
|
|||||
Unrealized
(gain) loss on adjustment of derivative and warrant liability to
fair
value of underlying securities
|
3,032,858
|
65,227,499
|
|||||
(Increase)
decrease in:
|
|||||||
Accounts
receivable
|
23,888
|
85,272
|
|||||
Inventories
|
103,128
|
88,393
|
|||||
Prepaid
expenses and other assets
|
(7,500
|
)
|
12,543
|
||||
Increase
(decrease) in:
|
|||||||
Cash
overdraft
|
(26,041
|
)
|
68,350
|
||||
Accounts
payable
|
372,758
|
92,929
|
|||||
Accrued
liabilities
|
633,076
|
343,689
|
|||||
Net
cash (used in) operating activities
|
(891,882
|
)
|
(1,793,351
|
)
|
|||
CASH
FLOWS FROM INVESTING ACTIVITIES:
|
|||||||
Net
cash acquired in connection with acquisition of Hybrid Lighting
Technologies, Inc
|
—
|
150,000
|
|||||
Acquisition
of fixed assets
|
—
|
(11,314
|
)
|
||||
Net
cash provided by (used in) investing activities:
|
—
|
138,686
|
|||||
CASH
FLOWS FROM FINANCING ACTIVITIES:
|
|||||||
Net
proceeds from issuance of convertible debentures
|
500,000
|
1,000,000
|
|||||
Proceeds
from sale of common stock
|
526,050
|
||||||
Proceeds
from exercise of warrants
|
—
|
—
|
|||||
Proceeds
from sale of warrants
|
—
|
158,723
|
|||||
Net
proceeds (payments) from borrowing on long term basis
|
(156,263
|
)
|
20,290
|
||||
Net
proceeds (payments) to notes payable, related parties
|
21,759
|
81,470
|
|||||
Net
cash provided by (used in) financing activities:
|
891,546
|
1,260,483
|
|||||
Net
increase (decrease) in cash and cash equivalents
|
(336
|
)
|
(394,182
|
)
|
|||
Cash
and cash equivalents at beginning of period
|
626
|
395,812
|
|||||
Cash
and cash equivalents at end of period
|
$
|
290
|
$
|
1,630
|
|||
Supplemental
disclosures:
|
|||||||
Interest
Paid
|
$
|
—
|
$
|
—
|
|||
Income
Taxes Paid
|
—
|
—
|
|||||
NON-CASH
INVESTING AND FINANCING ACTIVITIES:
|
|||||||
Unrealized
(gain) loss in adjustment of derivative and warrant liability to
fair
value of underlying securities
|
$
|
3,032,858
|
$
|
65,227,499
|
|||
Common
stock issued for services rendered
|
$
|
878,800
|
$
|
118,110
|
|||
Preferred
stock issued as compensation
|
$
|
—
|
$
|
370,500
|
|||
The
accompanying notes are an integral part of these condensed consolidated
financial statements
|
|
Three
Months Ended
September
30, 2008
|
|||
Net
income used in computing basic net income per share
|
$
|
910,568
|
||
Impact
of assumed assumptions:
|
||||
Accretion
of convertible debenture charged to interest expense
|
374,575
|
|||
Impact
of equity classified as liability:
|
||||
Gain
on warrant liability marked to fair value
|
(2,754,714
|
)
|
||
Net
loss in computing diluted net loss per share:
|
$
|
(1,469,571
|
)
|
Description
|
Cost
|
Accumulated amortization
and impairments
|
Net carrying value at
September
30, 2008
|
|||||||
Development
costs
|
$
|
293,750
|
$
|
293,750
|
$
|
-0-
|
||||
Patents
|
2,294,224
|
573,556
|
1,720,668
|
|||||||
Patents
|
1,387,000
|
346,750
|
1,040,250
|
|||||||
Total
|
$
|
3,974,974
|
$
|
1,214,056
|
$
|
2,760,918
|
|
September
30, 2008
|
December
31, 2007
|
|||||||||||||||||
|
Gross
Principal
Amount
|
Less:
Unamortized
Discount
|
Net
|
Gross
Principal
Amount
|
Less:
Unamortized
Discount
|
Net
|
|||||||||||||
10%
convertible note payable, unsecured and due September, 2003; accrued
and
unpaid interest due at maturity; Note holder has the option to convert
note principal together with accrued and unpaid interest to the Company’s
common stock at a rate of $0.50 per share. The Company is in violation
of
the loan covenants
|
$
|
2,500
|
—
|
$
|
2,500
|
$
|
2,500
|
—
|
$
|
2,500
|
|||||||||
|
|||||||||||||||||||
10%
convertible debenture, due three years from date of the note with
interest
payable quarterly during the life of the note. The note is convertible
into the Company’s common stock at the lower of a) $0.03 or b) 25% of the
average of the three lowest intraday trading prices for the common
stock
on a principal market for twenty days before, but not including,
conversion date. The Company granted the note holder a security interest
in substantially all of the Company’s assets and intellectual property and
registration rights. The Company is in violation of the loan covenants
(see below)
|
$
|
1,094,091
|
—
|
$
|
1,094,091
|
$
|
1,094,091
|
$
|
158,665
|
$
|
935,426
|
|
September
30, 2008
|
December
31, 2007
|
|||||||||||||||||
|
Gross
Principal
Amount
|
Less:
Unamortized
Discount
|
Net
|
Gross
Principal
Amount
|
Less:
Unamortized
Discount
|
Net
|
|||||||||||||
10%
convertible debenture, due three years from date of the note with
interest
payable quarterly during the life of the note. The note is convertible
into the Company’s common stock at the lower of a) $0.6 or b) 25% of the
average of the three lowest intraday trading prices for the common
stock
on a principal market for twenty days before, but not including,
conversion date. The Company granted the note holder a security interest
in substantially all of the Company’s assets and intellectual property and
registration rights. The Company is in violation of the loan covenants
(see below)
|
$
|
800,000
|
$
|
16,804
|
$
|
783,196
|
$
|
800,000
|
$
|
216,986
|
$
|
583,014
|
|||||||
8%
convertible debenture, due three years from date of the note with
interest
payable quarterly during the life of the note. The note is convertible
into the Company’s common stock at the lower of a) $0.10 or b) 25% of the
average of the three lowest intraday trading prices for the common
stock
on a principal market for twenty days before, but not including,
conversion date. The Company granted the note holder a security interest
in substantially all of the Company’s assets and intellectual property and
registration rights (see below)
|
700,000
|
56,256
|
643,744
|
700,000
|
231,416
|
468,584
|
|||||||||||||
8%
convertible debenture, due March 2009 with interest payable quarterly
during the life of the note. The note is convertible into the Company’s
common stock at the lower of a)$0.10 or b) 25% of the average of
the three
lowest intraday trading prices for the common stock on a principal
market
for twenty days before, but not including, conversion date. The Company
granted the note holder a security interest in substantially all
of the
Company’s assets and intellectual property and registration rights. (See
below)
|
500,000
|
80,822
|
419,178
|
500,000
|
205,936
|
294,064
|
|||||||||||||
|
|||||||||||||||||||
6%
convertible debenture, due July 2009 with interest payable quarterly
during the life of the note. The note is convertible into the Company’s
common stock at the lower of a)$0.10 or b) 25% of the average of
the three
lowest intraday trading prices for the common stock on a principal
market
for twenty days before, but not including, conversion date. The Company
granted the note holder a security interest in substantially all
of the
Company’s assets and intellectual property and registration rights. (See
below)
|
500,000
|
136,986
|
363,014
|
500,000
|
262,100
|
237,900
|
|||||||||||||
|
|||||||||||||||||||
6%
convertible debenture, due September 2009 with interest payable quarterly
during the life of the note. The note is convertible into the Company’s
common stock at the lower of a)$0.10 or b) 25% of the average of
the three
lowest intraday trading prices for the common stock on a principal
market
for twenty days before, but not including, conversion date. The Company
granted the note holder a security interest in substantially all
of the
Company’s assets and intellectual property and registration rights. (See
below)
|
$
|
280,000
|
$
|
92,055
|
$
|
187,945
|
$
|
280,000
|
$
|
162,119
|
$
|
117,881
|
|
September
30, 2008
|
December
31, 2007
|
|||||||||||||||||
|
Gross Principal
Amount
|
Less:
Unamortized
Discount
|
Net
|
Gross
Principal
Amount
|
Less:
Unamortized
Discount
|
Net
|
|||||||||||||
6%
convertible debenture, due December 2009 with interest payable quarterly
during the life of the note. The note is convertible into the Company’s
common stock at the lower of a)$0.10 or b) 25% of the average of
the three
lowest intraday trading prices for the common stock on a principal
market
for twenty days before, but not including, conversion date. The Company
granted the note holder a security interest in substantially all
of the
Company’s assets and intellectual property and registration rights. (See
below)
|
$
|
600,000
|
$
|
243,836
|
$
|
356,164
|
$
|
600,000
|
$
|
393,973
|
$
|
206,027
|
|||||||
8%
convertible debenture, due April 2010 with interest payable quarterly
during the life of the note. The note is convertible into the Company’s
common stock at the lower of a)$0.10 or b) 25% of the average of
the three
lowest intraday trading prices for the common stock on a principal
market
for twenty days before, but not including, conversion date. The Company
granted the note holder a security interest in substantially all
of the
Company’s assets and intellectual property and registration rights. (See
below)
|
400,000
|
206,027
|
193,973
|
400,000
|
306,119
|
93,881
|
|||||||||||||
8%
convertible debenture, due May 2010 with interest payable quarterly
during
the life of the note. The note is convertible into the Company’s common
stock at the lower of a)$0.10 or b) 25% of the average of the three
lowest
intraday trading prices for the common stock on a principal market
for
twenty days before, but not including, conversion date. The Company
granted the note holder a security interest in substantially all
of the
Company’s assets and intellectual property and registration rights. (See
below)
|
150,000
|
79,041
|
70,959
|
150,000
|
116,575
|
33,425
|
|||||||||||||
|
|||||||||||||||||||
8%
convertible debenture, due June 2010 with interest payable quarterly
during the life of the note. The note is convertible into the Company’s
common stock at the lower of a)$0.10 or b) 25% of the average of
the three
lowest intraday trading prices for the common stock on a principal
market
for twenty days before, but not including, conversion date. The Company
granted the note holder a security interest in substantially all
of the
Company’s assets and intellectual property and registration rights. (See
below)
|
150,000
|
83,288
|
66,712
|
150,000
|
120,822
|
29,178
|
|||||||||||||
|
|||||||||||||||||||
8%
convertible debenture, due June 2010 with interest payable quarterly
during the life of the note. The note is convertible into the Company’s
common stock at the lower of a)$0.10 or b) 25% of the average of
the three
lowest intraday trading prices for the common stock on a principal
market
for twenty days before, but not including, conversion date. The Company
granted the note holder a security interest in substantially all
of the
Company’s assets and intellectual property and registration rights. (See
below)
|
$
|
150,000
|
$
|
87,260
|
$
|
62,740
|
$
|
150,000
|
$
|
124,795
|
$
|
25,205
|
|
September
30, 2008
|
December
31, 2007
|
|||||||||||||||||
|
Gross Principal
Amount
|
Less:
Unamortized
Discount
|
Net
|
Gross
Principal
Amount
|
Less:
Unamortized
Discount
|
Net
|
|||||||||||||
8%
convertible debenture, due July 2010 with interest payable quarterly
during the life of the note. The note is convertible into the Company’s
common stock at the lower of a)$0.10 or b) 25% of the average of
the three
lowest intraday trading prices for the common stock on a principal
market
for twenty days before, but not including, conversion date. The Company
granted the note holder a security interest in substantially all
of the
Company’s assets and intellectual property and registration rights. (See
below)
|
$
|
150,000
|
$
|
89,041
|
$
|
60,959
|
$
|
150,000
|
$
|
126,575
|
$
|
23,425
|
|||||||
6%
convertible debenture (warrant), maturing March 2015 with interest
accruing until conversion. The warrant is exercisable at the greater
of a)
$0.012 or b) 75% of the average of three lowest intraday trading
prices
for the common stock on a principal market for twenty days before,
but
including, conversion date. The Company issued 6,763,300 shares of
its
common stock as security.
|
$
|
500,000
|
—
|
500,000
|
$
|
—
|
$
|
—
|
$
|
—
|
|||||||||
Total
|
5,976,591
|
(1,171,416
|
)
|
4,805,175
|
5,476,591
|
(2,426,081
|
)
|
3,050,510
|
|||||||||||
Less:
current maturities:
|
5,976,591
|
(1,171,416
|
)
|
4,805,175
|
5,476,591
|
(2,426,081
|
)
|
3,050,510
|
|||||||||||
Long
term portion
|
$
|
-0-
|
$
|
-0-
|
$
|
0-
|
$
|
-0-
|
$
|
-0-
|
$
|
-0-
|
|
·
|
Requirement
to pay principal and interest when due
|
|
·
|
Provide
shares of the Company’s common stock to the Holder(s) upon exercise by the
Holder(s)
|
|
·
|
Timely
file a registration statement with the SEC and obtain effectiveness
and
maintain effectiveness
|
|
·
|
Maintain
sufficient number of authorized shares, subject to Stockholder approval
for full conversion of any remaining Security Purchase
Agreement
|
|
·
|
Change
of control
|
|
·
|
Trading
market limitations
|
|
·
|
Requirement
to pay principal and interest when due
|
|
·
|
Provide
shares of the Company’s common stock to the Holder(s) upon exercise by the
Holder(s)
|
|
·
|
Timely
file a registration statement with the SEC and obtain effectiveness
and
maintain effectiveness
|
|
·
|
Maintain
sufficient number of authorized shares, subject to Stockholder approval
for full conversion of any remaining Security Purchase
Agreement
|
|
·
|
Change
of control
|
|
·
|
Trading
market limitations
|
|
·
|
Requirement
to pay principal and interest when due
|
|
·
|
Provide
shares of the Company’s common stock to the Holder(s) upon exercise by the
Holder(s)
|
|
·
|
Timely
file a registration statement with the SEC and obtain effectiveness
and
maintain effectiveness
|
|
·
|
Maintain
sufficient number of authorized shares, subject to Stockholder approval
for full conversion of any remaining Security Purchase
Agreement
|
|
·
|
Change
of control
|
|
·
|
Trading
market limitations
|
|
·
|
Requirement
to pay principal and interest when due
|
|
·
|
Provide
shares of the Company’s common stock to the Holder(s) upon exercise by the
Holder(s)
|
|
·
|
Timely
file a registration statement with the SEC and obtain effectiveness
and
maintain effectiveness
|
|
·
|
Maintain
sufficient number of authorized shares, subject to Stockholder approval
for full conversion of any remaining Security Purchase
Agreement
|
|
·
|
Change
of control
|
|
·
|
Trading
market limitations
|
|
·
|
Requirement
to pay principal and interest when due
|
|
·
|
Provide
shares of the Company’s common stock to the Holder(s) upon exercise by the
Holder(s)
|
|
·
|
Timely
file a registration statement with the SEC and obtain effectiveness
and
maintain effectiveness
|
|
·
|
Maintain
sufficient number of authorized shares, subject to Stockholder approval
for full conversion of any remaining Security Purchase
Agreement
|
|
·
|
Change
of control
|
|
·
|
Trading
market limitations
|
|
·
|
Requirement
to pay principal and interest when due
|
|
·
|
Provide
shares of the Company’s common stock to the Holder(s) upon exercise by the
Holder(s)
|
|
·
|
Timely
file a registration statement with the SEC and obtain effectiveness
and
maintain effectiveness
|
|
·
|
Maintain
sufficient number of authorized shares, subject to Stockholder approval
for full conversion of any remaining Security Purchase
Agreement
|
|
·
|
Change
of control
|
|
·
|
Trading
market limitations
|
|
·
|
Requirement
to pay principal and interest when due
|
|
·
|
Provide
shares of the Company’s common stock to the Holder(s) upon exercise by the
Holder(s)
|
|
·
|
Timely
file a registration statement with the SEC and obtain effectiveness
and
maintain effectiveness
|
|
·
|
Maintain
sufficient number of authorized shares, subject to Stockholder approval
for full conversion of any remaining Security Purchase
Agreement
|
|
·
|
Change
of control
|
|
·
|
Trading
market limitations
|
|
·
|
Requirement
to pay principal and interest when due
|
|
·
|
Provide
shares of the Company’s common stock to the Holder(s) upon exercise by the
Holder(s)
|
|
·
|
Timely
file a registration statement with the SEC and obtain effectiveness
and
maintain effectiveness
|
|
·
|
Maintain
sufficient number of authorized shares, subject to Stockholder approval
for full conversion of any remaining Security Purchase
Agreement
|
|
·
|
Change
of control
|
|
·
|
Trading
market limitations
|
|
·
|
Requirement
to pay principal and interest when due
|
|
·
|
Provide
shares of the Company’s common stock to the Holder(s) upon exercise by the
Holder(s)
|
|
·
|
Timely
file a registration statement with the SEC and obtain effectiveness
and
maintain effectiveness
|
|
·
|
Maintain
sufficient number of authorized shares, subject to Stockholder approval
for full conversion of any remaining Security Purchase
Agreement
|
|
·
|
Change
of control
|
|
·
|
Trading
market limitations
|
|
·
|
Requirement
to pay principal and interest when due
|
|
·
|
Provide
shares of the Company’s common stock to the Holder(s) upon exercise by the
Holder(s)
|
|
·
|
Timely
file a registration statement with the SEC and obtain effectiveness
and
maintain effectiveness
|
|
·
|
Maintain
sufficient number of authorized shares, subject to Stockholder approval
for full conversion of any remaining Security Purchase
Agreement
|
|
·
|
Change
of control
|
|
·
|
Trading
market limitations
|
|
·
|
Requirement
to pay principal and interest when due
|
|
·
|
Provide
shares of the Company’s common stock to the Holder(s) upon exercise by the
Holder(s)
|
|
·
|
Timely
file a registration statement with the SEC and obtain effectiveness
and
maintain effectiveness
|
|
·
|
Maintain
sufficient number of authorized shares, subject to Stockholder approval
for full conversion of any remaining Security Purchase
Agreement
|
|
·
|
Change
of control
|
|
·
|
Trading
market limitations
|
|
·
|
Requirement
to pay principal and interest when due
|
|
·
|
Provide
shares of the Company’s common stock to the Holder(s) upon exercise by the
Holder(s)
|
|
·
|
Timely
file a registration statement with the SEC and obtain effectiveness
and
maintain effectiveness
|
|
·
|
Maintain
sufficient number of authorized shares, subject to Stockholder approval
for full conversion of any remaining Security Purchase
Agreement
|
|
·
|
Change
of control
|
|
·
|
Trading
market limitations
|
|
·
|
The
Company allocated the proceeds received between convertible debt
and
detachable warrants based upon the relative fair market values on
the
dates the proceeds were received. The fair values of the detachable
warrants and the embedded derivatives were determined under the
Black-Scholes option pricing formula and the intrinsic method,
respectively
|
|
·
|
Subsequent
to the initial recording, the increase (or decease) in the fair value
of
the detachable warrants, determined under the Black-Scholes option
pricing
formula and the increase (or decrease) in the intrinsic value of
the
embedded derivatives of the convertible debentures are recorded as
adjustments to the liabilities at September 30, 2008 and December
31,
2007, respectively.
|
|
·
|
The
expense relating to the increase (or decrease) in the fair value
of the
Company’s stock reflected in the change in the fair value of the warrants
and derivatives is included as other income item as a gain or loss
arising
from convertible financing on the Company’s balance
sheet.
|
|
·
|
Accreted
principal of $4,805,175 and $3,048,010 as of September 30, 2008 and
December 31, 2007.
|
|
September
30,
2008
|
December 31,
2007
|
|||||
Fair
value of warrants relating to convertible debentures
|
$
|
412,451
|
$
|
1,874,970
|
|||
Fair
value of other outstanding warrants
|
565,487
|
2,634,568
|
|||||
Total
|
$
|
977,938
|
$
|
4,509,538
|
|
September
30,
2008
|
December 31,
2007
|
|||||
Expected
volatility
|
591
|
%
|
528
|
%
|
|||
Expected
dividend yield
|
-0-
|
%
|
-0-
|
%
|
|||
Average
risk free rate
|
0.92%
to 3.61
|
%
|
3.45
|
%
|
|||
Expected
life (a)
|
0.50
to 5.78 yrs
|
1.01
to 6.53 yrs
|
|
September
30,
2008
|
December 31, 2007
|
|||||
Note
payable, 24% interest per annum; due in 90 days; secured by specific
accounts receivables
|
$
|
39,804
|
$
|
196,067
|
|
September
30,
2008
|
December
31,
2007
|
|||||
Notes
payable, 12% per annum; due on demand; unsecured
|
$
|
158,473
|
$
|
147,714
|
|||
|
|||||||
Notes
payable, 10% per annum, due on demand; unsecured
|
260,350
|
249,350
|
|||||
|
418,823
|
397,064
|
|||||
Less:
current maturities:
|
(418,823
|
)
|
(397,064
|
)
|
|||
Long
term portion:
|
$
|
—
|
$
|
—
|
|
Subsequent
to the initial recording, the increase in the fair value of the detachable
warrants, determined under the Black- Scholes option pricing formula,
are
accrued as adjustments to the liabilities at September 30, 2008 and
December 31, 2007, respectively.
|
|
The
expense relating to the increase in the fair value of the Company's
stock
reflected in the change in the fair value of the warrants (noted
above) is
included as an other comprehensive income item of an unrealized gain
or
loss arising from convertible financing on the Company's balance
sheet.
|
Exercise Price
|
|
Number
Outstanding
|
|
Warrants
Outstanding
Weighted
Average
Remaining
Contractual
Life (years)
|
|
Weighted
Average
Exercise price
|
|
Number
Exercisable
|
|
Warrants
Exercisable
Weighted
Average
Exercise Price
|
|
||||||
$
|
0.001
|
|
|
50,000,000
|
|
|
4.02
|
|
$
|
0.001
|
|
|
50,000,000
|
|
|
0.001
|
|
0.02
|
|
|
50,000,000
|
|
|
3.68
|
|
|
0.02
|
|
|
50,000,000
|
|
|
0.02
|
|
|
0.03
|
|
|
25,000,000
|
|
|
1.63
|
|
|
0.03
|
|
|
25,000,000
|
|
|
0.03
|
|
|
0.10
|
|
|
991,500
|
|
|
0.68
|
|
|
0.10
|
|
|
991,500
|
|
|
0.10
|
|
|
0.25
|
|
|
58,500
|
|
|
0.25
|
|
|
0.25
|
|
|
58,500
|
|
|
0.25
|
|
|
0.50
|
|
|
50,000
|
|
|
0.03
|
|
|
0.50
|
|
|
50,000
|
|
|
0.50
|
|
|
1.05
|
|
|
100,000
|
|
|
0.25
|
|
|
1.05
|
|
|
100,000
|
|
|
1.05
|
|
|
0.06775
|
|
|
49,760,443
|
|
|
3.65
|
|
|
0.06775
|
|
|
49,760,443
|
|
|
0.03075
|
(a)
|
|
|
|
|
175,960,443
|
|
|
|
|
|
|
|
|
175,960,443
|
|
|
|
|
|
(a)
|
See
terms of warrants issued below
|
|
Number of Shares
|
|
Weighted Average
Price
Per Share
|
||||
Outstanding
at December 31, 2006
|
99,895,000
|
$
|
0.09
|
||||
Granted
|
200,000,000
|
0.01525
|
|||||
Exercised
|
(50,239,557
|
)
|
(0.03
|
)
|
|||
Canceled
or expired
|
(73,695,000
|
)
|
(0.07
|
||||
Outstanding
at December 31, 2007
|
175,960,443
|
0.016
|
|||||
Granted
|
—
|
—
|
|||||
Exercised
|
—
|
—
|
|||||
Canceled
or expired
|
—
|
—
|
|||||
Outstanding
at September 30, 2008
|
175,960,443
|
0.016
|
|
|
Options
Outstanding
|
|
|
|
Options
Exercisable
|
|
||||||||||
|
|
|
|
Weighted Average
|
|
Weighted
|
|
|
|
Weighted
|
|
||||||
|
|
|
|
Remaining
|
|
Average
|
|
|
|
Average
|
|
||||||
Exercise
|
|
Number
|
|
Contractual Life
|
|
Exercise
|
|
Number
|
|
Exercise
|
|
||||||
Prices
|
|
Outstanding
|
|
(Years)
|
|
Price
|
|
Exercisable
|
|
Price
|
|
||||||
$
|
0.2125
|
|
|
2,000,000
|
|
|
5.21
|
|
$
|
0.2125
|
|
|
2,000,000
|
|
$
|
0.2125
|
|
0.2125
|
|
|
2,000,000
|
|
|
5.62
|
|
|
0.2125
|
|
|
2,000,000
|
|
|
0.2125
|
|
|
0.022
|
|
|
20,500,000
|
|
|
8.12
|
|
|
0.022
|
|
|
20,500,000
|
|
|
0.022
|
|
|
0.0295
|
|
|
4,000,000
|
|
|
6.60
|
|
|
0.0295
|
|
|
4,000,000
|
|
|
0.0295
|
|
|
0.04
|
|
|
14,430,000
|
|
|
7.82
|
|
|
0.04
|
|
|
14,430,000
|
|
|
0.04
|
|
|
0.10
|
|
|
9,502,307
|
|
|
5.51
|
|
|
0.10
|
|
|
9,502,307
|
|
|
0.10
|
|
|
|
|
Weighted Average
|
|
|||
|
|
Number of Shares
|
|
Price Per Share
|
|||
Outstanding
at December 31, 2006
|
52,432,307
|
0.0562
|
|||||
Granted
|
—
|
—
|
|||||
Exercised
|
—
|
—
|
|||||
Canceled
or expired
|
—
|
—
|
|||||
Outstanding
at December 31, 2007
|
52,432,307
|
0.0562
|
|||||
Granted
|
—
|
—
|
|||||
Exercised
|
—
|
—
|
|||||
Canceled
or expired
|
—
|
—
|
|||||
Outstanding
at September 30, 2008
|
52,432,307
|
$
|
0.0562
|
2008
|
88,020
|
|||
2009
|
88,020
|
|||
2010
|
88,020
|
|||
2011
|
88,020
|
|||
2012
|
88,020
|
(a) |
Evaluation
of Disclosure Controls and
Procedures.
|
(b) |
Changes
in Internal Control Over Financial
Reporting
|
31.1 |
Certification
of Chief Executive Officer pursuant to Rule 13a-14 and Rule 15d-14(a),
promulgated under the Securities and Exchange Act of 1934, as
amended.
|
31.2 |
Certification
of Chief Financial Officer pursuant to Rule 13a-14 and Rule 15d 14(a),
promulgated under the Securities and Exchange Act of 1934, as
amended.
|
32.1 |
Certifications
pursuant to 18 U.S.C. Sectopm 1350 as adopted pursuant to Section
906 of
the Sarbanes Oxley Act of 2002.
|
CYBERLUX CORPORATION | ||
Date:
November 14, 2008
|
By: |
/s/
MARK D. SCHMIDT
|
Mark
D. Schmidt
|
||
Chief
Executive Officer (Principal Executive Officer)
|
||
Date:
November 14, 2008
|
By: |
/s/
DAVID D. DOWNING
|
David
D. Downing
|
||
Chief
Financial Officer (Principal Financial Officer and Principal Accounting
Officer)
|